Read + Share
Amedeo Smart
Independent Medical Education
Muller K, Vogiatzi F, Winterberg D, Rosner T, et al. Combining daratumumab with CD47 blockade prolongs survival in preclinical models of pediatric T-ALL. Blood 2022;140:45-57.PMID: 35452517
Email
LinkedIn
Facebook
Twitter
Privacy Policy